Nabriva Therapeutics AG ROA 2015-2018 | NBRV

Current and historical return on assets (ROA) values for Nabriva Therapeutics AG (NBRV) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Nabriva Therapeutics AG ROA for the three months ending December 31, 2018 was -80.84%.
Nabriva Therapeutics AG ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-12-31 $-0.12B $0.11B -112.47%
2018-09-30 $-0.11B $0.11B -107.34%
2018-06-30 $-0.08B $0.09B -74.44%
2018-03-31 $-0.07B $0.10B -75.20%
2017-12-31 $-0.07B $0.10B -81.77%
2017-09-30 $-0.07B $0.12B -74.65%
2017-06-30 $-0.06B $0.07B -72.84%
2017-03-31 $-0.06B $0.08B -63.28%
2016-12-31 $-0.06B $0.09B -57.29%
2016-09-30 $-0.06B $0.09B -61.61%
2016-06-30 $-0.05B $0.10B -43.17%
2016-03-31 $-0.04B $0.11B -48.18%
2015-12-31 $-0.04B $0.12B -61.42%
2015-09-30 $-0.02B $0.13B -45.39%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.916B $0.010B
Nabriva Therapeutics is a biopharmaceutical company engaged in the research and development of new medicines to treat serious bacterial infections, with a focus on the pleuromutilin class of antibiotics. Nabriva Therapeutics' medicinal chemistry expertise has enabled targeted discovery of novel pleuromutilins, including both intravenous and oral formulations. Nabriva Therapeutics' lead product candidate, lefamulin, is a novel semi-synthetic pleuromutilin antibiotic with the potential to be the first-in-class available for systemic administration in humans. The company believes that lefamulin is the first antibiotic with a novel mechanism of action to have reached late-stage clinical development in more than a decade. Nabriva has announced positive topline data for lefamulin from the first of its two global, registrational Phase 3 clinical trials evaluating lefamulin in patients with moderate to severe community-acquired bacterial pneumonia (CABP).
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.004B 13.27
Gilead Sciences (GILD) United States $83.712B 10.65
Biogen (BIIB) United States $64.888B 12.57
Celgene (CELG) United States $62.130B 11.49
Vertex Pharmaceuticals (VRTX) United States $48.087B 64.41
Illumina (ILMN) United States $45.546B 54.17
Regeneron Pharmaceuticals (REGN) United States $45.292B 21.04
Alexion Pharmaceuticals (ALXN) United States $30.412B 18.85
Incyte (INCY) United States $18.152B 169.60
BioMarin Pharmaceutical (BMRN) United States $16.862B 0.00
Seattle Genetics (SGEN) United States $11.981B 0.00
Exact Sciences (EXAS) United States $11.972B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.715B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.348B 53.33
Sarepta Therapeutics (SRPT) United States $9.151B 0.00
QIAGEN (QGEN) Netherlands $8.984B 29.73
Bluebird Bio (BLUE) United States $8.684B 0.00
Guardant Health (GH) United States $8.402B 0.00
BeiGene (BGNE) Cayman Islands $8.080B 0.00
Bio-Techne Corp (TECH) United States $7.389B 49.78
Exelixis (EXEL) United States $7.362B 17.15
Moderna (MRNA) United States $7.179B 0.00
Amarin (AMRN) Ireland $6.565B 0.00
Ascendis Pharma (ASND) Denmark $5.388B 0.00
Alkermes (ALKS) Ireland $5.308B 0.00
Array BioPharma (ARRY) United States $5.159B 0.00
Galapagos (GLPG) Belgium $5.061B 0.00
Horizon Pharma Public (HZNP) Ireland $4.731B 15.24
Spark Therapeutics (ONCE) United States $4.312B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.255B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.863B 0.00
Blueprint Medicines (BPMC) United States $3.781B 0.00
Immunomedics (IMMU) United States $3.534B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.501B 0.00
China Biologic Products (CBPO) China $3.406B 21.11
Intercept Pharmaceuticals (ICPT) United States $3.361B 0.00
Allogene Therapeutics (ALLO) United States $3.248B 0.00
Amicus Therapeutics (FOLD) United States $3.094B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.025B 0.00
Global Blood Therapeutics (GBT) United States $2.964B 0.00
Reata Pharmaceuticals (RETA) United States $2.824B 0.00
Genomic Health (GHDX) United States $2.749B 70.28
Mirati Therapeutics (MRTX) United States $2.691B 0.00
Akcea Therapeutics (AKCA) United States $2.684B 0.00
Repligen (RGEN) United States $2.641B 81.26
Emergent Biosolutions (EBS) United States $2.559B 21.36
Myriad Genetics (MYGN) United States $2.466B 25.11
Acceleron Pharma (XLRN) United States $2.436B 0.00
Ligand Pharmaceuticals (LGND) United States $2.434B 18.17
UniQure (QURE) Netherlands $2.384B 0.00
Halozyme Therapeutics (HALO) United States $2.332B 0.00
Denali Therapeutics (DNLI) United States $2.327B 0.00
Insmed (INSM) United States $2.297B 0.00
Arena Pharmaceuticals (ARNA) United States $2.297B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.218B 0.00
MyoKardia (MYOK) United States $2.121B 0.00
REGENXBIO (RGNX) United States $2.095B 21.87
CRISPR Therapeutics AG (CRSP) Switzerland $2.020B 0.00
Medicines (MDCO) United States $2.004B 0.00
AnaptysBio (ANAB) United States $1.941B 0.00
NeoGenomics (NEO) United States $1.881B 153.00
Atara Biotherapeutics (ATRA) United States $1.770B 0.00
Allakos (ALLK) United States $1.697B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.684B 0.00
Audentes Therapeutics (BOLD) United States $1.630B 0.00
Myovant Sciences (MYOV) United Kingdom $1.565B 0.00
WAVE Life Sciences (WVE) Singapore $1.564B 0.00
Puma Biotechnology (PBYI) United States $1.508B 0.00
Aimmune Therapeutics (AIMT) United States $1.459B 0.00
Clovis Oncology (CLVS) United States $1.451B 0.00
Innoviva (INVA) United States $1.432B 3.94
Momenta Pharmaceuticals (MNTA) United States $1.394B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.366B 0.00
Cambrex (CBM) United States $1.331B 14.33
GOSSAMER BIO (GOSS) United States $1.296B 0.00
Rubius Therapeutics (RUBY) United States $1.288B 0.00
ALECTOR INC (ALEC) United States $1.234B 0.00
Lion Biotechnologies (IOVA) United States $1.227B 0.00
Fate Therapeutics (FATE) United States $1.216B 0.00
Editas Medicine (EDIT) United States $1.192B 0.00
Apellis Pharmaceuticals (APLS) United States $1.190B 0.00
RA PHARMCTL INC (RARX) United States $1.148B 0.00
Codexis (CDXS) United States $1.143B 0.00
Epizyme (EPZM) United States $1.110B 0.00
InflaRx (IFRX) Germany $1.110B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.033B 0.00
Coherus BioSciences (CHRS) United States $0.998B 0.00
Sangamo Therapeutics (SGMO) United States $0.996B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.992B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.986B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.966B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.963B 38.92
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.947B 0.00
Retrophin (RTRX) United States $0.947B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.925B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.881B 0.00
Principia Biopharma (PRNB) United States $0.881B 0.00
Vericel (VCEL) United States $0.840B 0.00
Cellectis (CLLS) France $0.803B 0.00
Athenex (ATNX) United States $0.796B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.785B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.783B 0.00
Intellia Therapeutics (NTLA) United States $0.755B 0.00
ANI Pharmaceuticals (ANIP) United States $0.752B 13.77
Intra-Cellular Therapies (ITCI) United States $0.740B 0.00
Eidos Therapeutics (EIDX) United States $0.725B 0.00
Cara Therapeutics (CARA) United States $0.722B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.717B 0.00
Acorda Therapeutics (ACOR) United States $0.697B 9.03
Inotek Pharmaceuticals (RCKT) United States $0.691B 0.00
Revance Therapeutics (RVNC) United States $0.680B 0.00
Osiris Therapeutics (OSIR) United States $0.658B 0.00
Heska (HSKA) United States $0.626B 56.14
Synthorx (THOR) United States $0.617B 0.00
Twist Bioscience (TWST) United States $0.613B 0.00
Kura Oncology (KURA) United States $0.591B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.588B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.586B 0.00
G1 THERAPEUTICS (GTHX) United States $0.584B 0.00
MeiraGTx Holdings (MGTX) United States $0.581B 0.00
ObsEva SA (OBSV) Switzerland $0.576B 0.00
Magenta Therapeutics (MGTA) United States $0.574B 0.00
Prothena (PRTA) Ireland $0.572B 0.00
Arvinas (ARVN) United States $0.566B 0.00
Viking Therapeutics (VKTX) United States $0.566B 0.00
UROGEN PHARMA (URGN) Israel $0.523B 0.00
Arcus Biosciences (RCUS) United States $0.520B 0.00
PDL BioPharma (PDLI) United States $0.518B 10.14
NuCana Sponsored ADR (NCNA) United Kingdom $0.512B 0.00
Dynavax Technologies (DVAX) United States $0.509B 0.00
Zymeworks (ZYME) Canada $0.490B 0.00
DBV Technologies (DBVT) France $0.490B 0.00
CytomX Therapeutics (CTMX) United States $0.481B 0.00
Zealand Pharma (ZEAL) Denmark $0.476B 5.24
Senesco Technologies (ELOX) United States $0.465B 0.00
Scholar Rock Holding (SRRK) United States $0.457B 0.00
Five Prime Therapeutics (FPRX) United States $0.451B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.440B 0.00
Stemline Therapeutics (STML) United States $0.433B 0.00
Cytokineticsorporated (CYTK) United States $0.428B 0.00
Urovant Sciences (UROV) United States $0.428B 0.00
Anika Therapeutics (ANIK) United States $0.426B 16.11
Achillion Pharmaceuticals (ACHN) United States $0.423B 0.00
Mesoblast (MESO) Australia $0.412B 0.00
MannKind (MNKD) United States $0.412B 0.00
STEALTH BIOTHER (MITO) United States $0.411B 0.00
BeyondSpring (BYSI) United States $0.399B 0.00
Abeona Therapeutics (ABEO) United States $0.388B 0.00
Albireo Pharma (ALBO) United States $0.380B 0.00
AVROBIO (AVRO) United States $0.376B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.375B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
MediciNova (MNOV) United States $0.367B 0.00
Replimune (REPL) United States $0.364B 0.00
UNITY Biotechnology (UBX) $0.362B 0.00
Kindred Biosciences (KIN) United States $0.356B 0.00
Solid Biosciences (SLDB) United States $0.356B 0.00
BioDelivery Sciences (BDSI) United States $0.353B 0.00
Kadmon Holdings (KDMN) United States $0.352B 0.00
Kezar Life Sciences (KZR) United States $0.348B 0.00
Agenus (AGEN) United States $0.344B 0.00
Inovio Pharmaceuticals (INO) United States $0.344B 0.00
Adverum Biotechnologies (ADVM) United States $0.340B 0.00
XBiotech (XBIT) United States $0.331B 0.00
OSMOTICA PHARM (OSMT) United States $0.329B 0.00
Aduro Biotech (ADRO) United States $0.328B 0.00
Axsome Therapeutics (AXSM) United States $0.325B 0.00
Geron (GERN) United States $0.311B 0.00
Krystal Biotech (KRYS) United States $0.305B 0.00
AC Immune SA (ACIU) Switzerland $0.304B 0.00
Gritstone Oncology (GRTS) United States $0.295B 0.00
Merus (MRUS) Netherlands $0.295B 0.00
Kala Pharmaceuticals (KALA) United States $0.294B 0.00
Syros Pharmaceuticals (SYRS) United States $0.291B 0.00
Cellular Biomedicine (CBMG) United States $0.290B 0.00
Strongbridge Biopharma (SBBP) United States $0.288B 0.00
Sorrento Therapeutics (SRNE) United States $0.285B 0.00
Evelo Biosciences (EVLO) United States $0.285B 0.00
Gamida Cell (GMDA) Israel $0.279B 0.00
Enochian BioSciences (ENOB) United States $0.271B 0.00
Seres Therapeutics (MCRB) United States $0.270B 0.00
Protagonist Therapeutics (PTGX) United States $0.269B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.267B 0.00
Sutro Biopharma (STRO) United States $0.262B 0.00
Liquidia Technologies (LQDA) United States $0.260B 0.00
Constellation Pharmaceuticals (CNST) United States $0.258B 0.00
Kodiak Sciences (KOD) United States $0.257B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.256B 0.00
Kamada (KMDA) Israel $0.247B 11.16
ResTORbio (TORC) United States $0.246B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.240B 0.00
TOCAGEN INC (TOCA) United States $0.239B 0.00
Mersana Therapeutics (MRSN) United States $0.238B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.236B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.234B 0.00
Cerecor (CERC) United States $0.232B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.231B 0.00
Verastem (VSTM) United States $0.230B 0.00
Spero Therapeutics (SPRO) United States $0.229B 0.00
Intec Pharma (NTEC) Israel $0.227B 0.00
LogicBio Therapeutics (LOGC) United States $0.226B 0.00
Axovant Sciences (AXGT) United Kingdom $0.221B 0.00
Arbutus Biopharma (ABUS) Canada $0.215B 0.00
Athersys (ATHX) United States $0.214B 0.00
Celyad SA (CYAD) Belgium $0.213B 0.00
Proteostasis Therapeutics (PTI) United States $0.210B 0.00
ChromaDex (CDXC) United States $0.209B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.207B 0.00
Celcuity (CELC) United States $0.205B 0.00
Synlogic (SYBX) United States $0.199B 0.00
VBI Vaccines (VBIV) United States $0.195B 0.00
Novavax (NVAX) United States $0.195B 0.00
Compugen (CGEN) Israel $0.191B 0.00
ADMA Biologics Inc (ADMA) United States $0.185B 0.00
Menlo Therapeutics (MNLO) United States $0.182B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.180B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.178B 0.00
OvaScience (MLND) United States $0.176B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.173B 0.00
Cue Biopharma (CUE) United States $0.166B 0.00
Cohbar (CWBR) United States $0.162B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.162B 0.00
Chiasma (CHMA) United States $0.161B 0.00
BioXcel Therapeutics (BTAI) United States $0.152B 0.00
Allena Pharmaceuticals (ALNA) United States $0.152B 0.00
Trevena (TRVN) United States $0.143B 0.00
Anavex Life Sciences (AVXL) United States $0.141B 0.00
Aptinyx (APTX) United States $0.138B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.136B 0.00
Eton Pharmaceuticals (ETON) United States $0.132B 0.00
Equillium (EQ) United States $0.128B 0.00
XOMA (XOMA) United States $0.128B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.128B 0.00
Unum Therapeutics (UMRX) United States $0.127B 0.00
Organovo Holdings (ONVO) United States $0.125B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.125B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.123B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
Pluristem Therapeutics (PSTI) Israel $0.116B 0.00
Mustang Bio (MBIO) United States $0.116B 0.00
Catalyst Biosciences (CBIO) United States $0.113B 0.00
Fortress Biotech (FBIO) United States $0.113B 0.00
Checkpoint Therapeutics (CKPT) United States $0.111B 0.00
Neothetics (EVFM) United States $0.106B 0.00
VTv Therapeutics (VTVT) United States $0.106B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.098B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.097B 0.00
NantKwest (NK) United States $0.096B 0.00
PHASEBIO PHARMA (PHAS) United States $0.091B 0.00
Oncobiologics (OTLK) United States $0.091B 0.00
Cocrystal Pharma (COCP) United States $0.087B 96.67
Signal Genetics (MGEN) United States $0.087B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.084B 0.00
Alimera Sciences (ALIM) United States $0.083B 0.00
Idera Pharmaceuticals (IDRA) United States $0.082B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.082B 0.00
Provention Bio (PRVB) United States $0.081B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.081B 0.00
Applied Genetic Technologies (AGTC) United States $0.080B 0.00
Orgenesis (ORGS) United States $0.079B 0.00
Aptose Biosciences (APTO) Canada $0.077B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.076B 0.00
SESEN BIO, INC (SESN) United States $0.075B 0.00
OVID THERAPEUTC (OVID) United States $0.074B 0.00
NewLink Genetics (NLNK) United States $0.071B 0.00
INMUNE BIO INC (INMB) United States $0.069B 0.00
Cidara Therapeutics (CDTX) United States $0.068B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.068B 0.00
Proteon Therapeutics (PRTO) United States $0.068B 0.00
ARAVIVE, INC (ARAV) United States $0.067B 0.00
Eyenovia (EYEN) United States $0.067B 0.00
AEterna Zentaris (AEZS) United States $0.065B 12.38
Ophthotech (OPHT) United States $0.065B 0.00
ScPharmaceuticals (SCPH) United States $0.063B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.062B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.062B 0.00
Prima BioMed (IMMP) Australia $0.062B 0.00
Vascular Biogenics (VBLT) Israel $0.060B 0.00
Celldex Therapeutics (CLDX) United States $0.059B 0.00
Zosano Pharma (ZSAN) United States $0.057B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.056B 0.00
VistaGen Therapeutics (VTGN) United States $0.054B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.054B 0.00
Alcobra (ARCT) United States $0.054B 0.00
ANCHIANO THERAP (ANCN) Israel $0.052B 0.00
Bionano Genomics (BNGO) United States $0.050B 0.00
Evogene (EVGN) Israel $0.050B 0.00
Entera Bio (ENTX) Israel $0.049B 0.00
VIVUS (VVUS) United States $0.049B 0.00
Selecta Biosciences (SELB) United States $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.048B 0.00
Leap Therapeutics (LPTX) United States $0.048B 0.00
Bellerophon Therapeutics (BLPH) United States $0.048B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
Vaccinex (VCNX) United States $0.045B 0.00
Celsion (CLSN) United States $0.042B 0.00
TRACON Pharmaceuticals (TCON) United States $0.042B 0.00
Caladrius Biosciences (CLBS) United States $0.039B 0.00
DiaMedica Therapeutics (DMAC) United States $0.039B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.038B 0.00
Moleculin Biotech (MBRX) United States $0.036B 0.00
AZURRX BIOPHARM (AZRX) United States $0.035B 0.00
OncoSec Medical (ONCS) United States $0.034B 0.00
Sophiris Bio (SPHS) United States $0.032B 0.00
Adial Pharmaceuticals (ADIL) United States $0.032B 0.00
GENPREX INC (GNPX) United States $0.032B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.031B 0.00
GTx (GTXI) United States $0.031B 0.00
Oncolytics Biotech (ONCY) Canada $0.031B 0.00
Advaxis (ADXS) United States $0.030B 0.00
Galena Biopharma (SLS) United States $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.028B 0.00
Vical (VICL) United States $0.026B 0.00
IMMURON LTD (IMRN) Australia $0.025B 0.00
Novelion Therapeutics (NVLN) Canada $0.024B 0.00
Motif Bio Plc (MTFB) United States $0.024B 0.00
CytRx (CYTR) United States $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Benitec Biopharma (BNTC) Australia $0.020B 0.00
Aytu Bioscience (AYTU) United States $0.019B 0.00
Aptevo Therapeutics (APVO) United States $0.019B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Apricus Biosciences (SEEL) United States $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.017B 0.00
RestorGenex (DFFN) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Therapix Biosciences (TRPX) Israel $0.016B 7.98
Edge Therapeutics (EDGE) United States $0.016B 0.00
Soligenix (SNGX) United States $0.016B 0.00
TrovaGene (TROV) United States $0.015B 0.00
Genetic Technologies (GENE) Australia $0.015B 0.00
ATyr Pharma (LIFE) United States $0.014B 0.00
Alliqua BioMedical (ALQA) United States $0.014B 0.00
Pulmatrix (PULM) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
Dare Bioscience (DARE) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Neuralstem (CUR) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Histogenics (HSGX) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Flex Pharma (FLKS) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Tenax Therapeutics (TENX) United States $0.003B 0.00
HOTH THERAPEUTC (HOTH) United States $0.000B 0.00
Arsanis (XFOR) United States $0.000B 0.00